Clinical trial
Paclitaxel Plus Carboplatin With or Without Topotecan in Treating Patients With…
NCT00006454 · AGO Study Group, Other · Completed
Key facts
| NCT number | NCT00006454 |
|---|---|
| Title | Paclitaxel Plus Carboplatin With or Without Topotecan in Treating Patients With Stage IIB, Stage III, or Stage IV Ovarian Epithelial Cancer |
| Official title | Phase III Multicenter Study in Epithelial Ovarian Carcinoma FIGO Stage IIB-IV Comparing Treatment With Paclitaxel and Carboplatin to Paclitaxel and Carboplatin Sequentially Followed by Topotecan |
| Lead sponsor | AGO Study Group, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Fallopian Tube Cancer, Ovarian Cancer |
| Intervention type | Drug |
| Interventions | carboplatin, paclitaxel, topotecan hydrochloride |
| Start date | Dec 1, 1999 |
| Primary completion | Aug 1, 2006 |
| Completion | Aug 1, 2006 |
| First posted | Feb 3, 2004 |
| Last update posted | Dec 23, 2015 |
| Countries | Germany |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: